Skip to search formSkip to main contentSkip to account menu

TOFACITINIB CITRATE

Known as: 1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-Pyrrolo(2,3-d)Pyrimidin-4-ylamino)-Beta-Oxo-, (3R,4R)-, 2-Hydroxy-1,2,3-Propanetricarboxylate (1:1) 
National Institutes of Health

Related topics

Related topics

4 relations
Receptor Tyrosine Kinase Inhibitiontofacitinib 5 MG Oral Tablet [Xeljanz]

Narrower (1)

Xeljanz

Broader (1)

tofacitinib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
JAK inhibitors: A broadening approach in rheumatoid arthritis.
Pfizer's Xeljanz (tofacitinib citrate) was the first Janus kinase (JAK) inhibitor to reach the market for rheumatoid arthritis… 
2016
2016
Preparation method of tofacitinib citrate
The invention belongs to the field of medicine and chemical engineering and particularly relates to a preparation method of… 
2016
2016
Tofacitinib citrate tablets and preparation method thereof
The invention discloses Tofacitinib citrate tablets composed of Tofacitinib citrate and pharmaceutically acceptable auxiliary… 
2015
2015
Determination of Four Enantiomers in Tofacitinib Citrate by HPLC
建立了高效液相色谱法同时测定枸橼酸托法替布中的4种光学异构体.采用Chiralpak IC色谱柱,以甲基叔丁醚∶乙醇∶二乙胺(70∶30∶0.1)为流动相,检测波长为280 nm.4种光学异构体之间的分离度均大于2.0,线性范围为0.1～120 μg/ml… 
2015
2015
Tofacitinib citrate synthesizing method
The invention belongs to the field of medicine synthesis and particularly relates to a Tofacitinib citrate synthesizing method… 
2014
2014
Preparation method of tofacitinib citrate
The invention relates to a method for preparing tofacitinib citrate. The method comprises the following steps: by taking N-methyl… 
Review
2014
Review
2014
Pharmacological and clinical studies of tofacitinib citrate
Tofacitinib citrate,an inhibitor of Janus kinases(JAKs),is indicated for the treatment of adult patients with moderately to… 
2014
2014
Chapter Twenty-Five - Case History: Xeljanz™ (Tofacitinib Citrate), a First-in-Class Janus Kinase Inhibitor for the Treatment of Rheumatoid Arthritis
2014
2014
Content determining and related substance detection method for tofacitinib citrate
The invention discloses a content determining and related substance detection method for tofacitinib citrate. The method is… 
Review
2013
Review
2013
New therapeutic agents marketed in the second half of 2012: Part 1
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)